Dr. Andrews is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5777 E Mayo Blvd
Phoenix, AZ 85054Phone+1 480-301-8000
Summary
- Jack R. Andrews M.D., is a fellowship-trained urologic oncologist with subspecialty expertise in the multidisciplinary management of urologic cancers. He completed his Urology residency at the Mayo Clinic in Rochester Minnesota and his Urologic Oncology fellowship at MD Anderson Cancer Center in Houston Texas.
While treating all urologic malignancies, Dr. Andrews clinical and research focus is in prostate cancer. He performs robotic nerve sparing prostatectomy, transperineal MRI fusion prostate biopsy and PSMA PET directed metastasis directed therapy.
In addition to his clinical practice, Dr. Andrews isan active surgeon-scientist with multiple research grants, publishing regularly in the peer-reviewed scientific literature. He is an active clinical trial investigator and is currently recruiting for multiple clinical trials investigating novel therapies for the treatment of prostate cancer.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2021 - 2023
Mayo Clinic College of Medicine and Science (Rochester)Residency, Urology, 2016 - 2021
University of Oklahoma College of MedicineClass of 2016
Certifications & Licensure
AZ State Medical License 2021 - 2026
TX State Medical License 2021 - 2026
MN State Medical License 2017 - 2025
Awards, Honors, & Recognition
- SWOG Vogelzang Scholar 2023
- AUA Care Foundation Scholar 2021-2023
- Mayo Clinic Scholar
- Join now to see all
Publications & Presentations
PubMed
- Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [Lu]Lu-PSMA-617.Miguel Muniz, Oliver Sartor, Jacob J Orme, Regina M Koch, Hana R Rosenow
Journal of Nuclear Medicine. 2024-12-03 - Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes.Mohamed E Ahmed, Jack R Andrews, Ahmed M Mahmoud, Giuseppe Reitano, Prabin Thapa
The Journal of Urology. 2024-12-02 - In-field prostate cancer recurrence following radical prostatectomy and salvage radiation.Austin Martin, Ahmed M Mahmoud, Cameron J Britton, Anthony Fadel, Mohamed E Ahmed
BJU International. 2024-11-30
Press Mentions
Metastasis-Directed Therapy May Delay ADT in Advanced Prostate CancerNovember 29th, 2022- Little Less Talk and a Lot More ActionMay 21st, 2024
- Psychology | a Classmate’s Mental Health Disorder Increases the Risk of One’s Own Symptoms – Researchers Urge Schools to Take ActionMay 28th, 2024
Grant Support
- Gosselin Cancer Center GrantMayo Clinic2023–Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
